HomeSUPN • NASDAQ
add
Supernus Pharmaceuticals Inc
Previous close
$29.16
Day range
$28.70 - $29.32
Year range
$21.99 - $35.96
Market cap
1.60B USD
Avg Volume
443.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 143.64M | -6.58% |
Operating expense | 131.58M | 3.79% |
Net income | 124.00K | -99.27% |
Net profit margin | 0.09 | -99.18% |
Earnings per share | — | — |
EBITDA | 16.50M | -31.62% |
Effective tax rate | 48.97% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 297.74M | 30.26% |
Total assets | 1.30B | -27.22% |
Total liabilities | 374.92M | -57.38% |
Total equity | 929.17M | — |
Shares outstanding | 54.97M | — |
Price to book | 1.73 | — |
Return on assets | -0.82% | — |
Return on capital | -1.10% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 124.00K | -99.27% |
Cash from operations | 38.40M | -21.83% |
Cash from investing | -51.62M | -121.53% |
Cash from financing | 1.57M | -98.04% |
Net change in cash | -11.65M | -103.16% |
Free cash flow | 38.95M | 110.05% |
About
Founded
2005
Headquarters
Website
Employees
652